PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,000 | -50.0% | 300 | -40.0% | 0.00% | -66.7% |
| Q2 2014 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |